Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Payables: 2009-2024

Historic Payables for Cross Country Healthcare (CCRN) over the last 16 years, with FY2024 value amounting to $64.9 million.

  • Cross Country Healthcare's Payables fell 2759.43% to $42.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.3 million, marking a year-over-year decrease of 2759.43%. This contributed to the annual value of $64.9 million for FY2024, which is 3003.17% down from last year.
  • Per Cross Country Healthcare's latest filing, its Payables stood at $64.9 million for FY2024, which was down 3003.17% from $92.8 million recorded in FY2023.
  • Cross Country Healthcare's 5-year Payables high stood at $193.0 million for FY2022, and its period low was $49.9 million during FY2020.
  • In the last 5 years, Cross Country Healthcare's Payables had a median value of $92.8 million in 2023 and averaged $102.1 million.
  • Per our database at Business Quant, Cross Country Healthcare's Payables soared by 12004.73% in 2021 and then plummeted by 5190.47% in 2023.
  • Over the past 5 years, Cross Country Healthcare's Payables (Annual) stood at $49.9 million in 2020, then surged by 120.05% to $109.8 million in 2021, then soared by 75.85% to $193.0 million in 2022, then crashed by 51.9% to $92.8 million in 2023, then tumbled by 30.03% to $64.9 million in 2024.
  • Its Payables stands at $64.9 million for FY2024, versus $92.8 million for FY2023 and $193.0 million for FY2022.